Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | SSTR3 | P32745 | 4/20 | 0.38 |
| ▸ | SSTR5 | P35346 | 4/20 | 0.38 |
| ▸ | SSTR2 | P30874 | 2/20 | 0.38 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.38 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.38 |
| ▸ | STS | P08842 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | YAP1 | P46937 | 1/20 | 0.36 |
| ▸ | MCHR1 | Q99705 | 3/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | KLK7 | P49862 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26349638 | 0.81 | SSTR3 (0.41) | SSTR3SSTR5SSTR2SSTR1SSTR4 | |
| SCHEMBL29410615 | 0.77 | SSTR3 (0.41) | L3MBTL1SSTR3SSTR5SSTR2SSTR1 | |
| SCHEMBL29410617 | 0.76 | PTPN1 (0.42) | L3MBTL1 | |
| SCHEMBL15143128 | 0.76 | L3MBTL1 (0.50) | L3MBTL1SSTR3SSTR5SSTR2SSTR1 | |
| SCHEMBL30530241 | 0.75 | SSTR3 (0.41) | SSTR3SSTR5SSTR2SSTR1SSTR4 | |
| SCHEMBL15504386 | 0.71 | L3MBTL1 (0.41) | L3MBTL1KLK7 | |
| SCHEMBL26878507 | 0.71 | LMNA (0.45) | L3MBTL1SSTR3SSTR5SSTR2SSTR1 | |
| SCHEMBL21058342 | 0.69 | SSTR3 (0.48) | SSTR3SSTR5SSTR2SSTR1SSTR4 | |
| SCHEMBL26349670 | 0.69 | NPC1 (0.40) | SMN1; SMN2 | |
| SCHEMBL15087298 | 0.68 | L3MBTL1 (0.39) | L3MBTL1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230303618-A1 | TRIPTOLIDE CONJUGATES AND USES THEREOF | REYOUNG CORPORATION (US) | 2023-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230303618-A1 | TRIPTOLIDE CONJUGATES AND USES THEREOF | TLR9, XIAP, ENPP2 | GPR119 821/4885L3MBTL1 1782/4885SSTR3 3941/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.